Long-Term Outcomes After One-Anastomosis Gastric Bypass (OAGB) in Morbidly Obese Patients.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 25 11 2019
medline: 15 4 2021
entrez: 25 11 2019
Statut: ppublish

Résumé

One-anastomosis gastric bypass (OAGB) has gradually gained in popularity. Evidence of the validity of the technique and the quality of life in the longer term is scarce. The aim of this study was to retrospectively evaluate the longitudinal (≥ 5 years) safety, weight-loss efficacy, comorbid disease improvement, and quality of life of patients following OAGB. Data from patients who underwent OAGB from January 2009 to December 2011 were retrospectively reviewed. Preoperative clinical characteristics and data through 8 years were analyzed. A total of 163 patients completed 5 to 8 years of follow-up with a mean age of 41 ± 11.4 years (22-65). Ninety-four patients (57.6%) had undergone prior bariatric surgery (gastric band). Mean body mass index (BMI, kg/m OAGB provided very good weight loss, comorbidity improvement, and quality of life at follow-up of ≥ 5 years.

Sections du résumé

BACKGROUND
One-anastomosis gastric bypass (OAGB) has gradually gained in popularity. Evidence of the validity of the technique and the quality of life in the longer term is scarce. The aim of this study was to retrospectively evaluate the longitudinal (≥ 5 years) safety, weight-loss efficacy, comorbid disease improvement, and quality of life of patients following OAGB.
METHODS
Data from patients who underwent OAGB from January 2009 to December 2011 were retrospectively reviewed. Preoperative clinical characteristics and data through 8 years were analyzed.
RESULTS
A total of 163 patients completed 5 to 8 years of follow-up with a mean age of 41 ± 11.4 years (22-65). Ninety-four patients (57.6%) had undergone prior bariatric surgery (gastric band). Mean body mass index (BMI, kg/m
CONCLUSION
OAGB provided very good weight loss, comorbidity improvement, and quality of life at follow-up of ≥ 5 years.

Identifiants

pubmed: 31760607
doi: 10.1007/s11695-019-04287-4
pii: 10.1007/s11695-019-04287-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1379-1384

Références

Obes Surg. 2003 Oct;13(5):684-92
pubmed: 14627461
Obes Surg. 2018 May;28(5):1441-1444
pubmed: 29516398
Obes Surg. 2017 Sep;27(9):2222-2228
pubmed: 28361493
Obes Surg. 2001 Jun;11(3):276-80
pubmed: 11433900
Obes Surg. 2014 Oct;24(10):1749-56
pubmed: 25056233
Am J Surg. 2016 Jan;211(1):250-67
pubmed: 26341463
Int J Obes (Lond). 2007 Apr;31(4):569-77
pubmed: 17325689
Obes Surg. 2018 Sep;28(9):2956-2967
pubmed: 29995293
World J Gastrointest Endosc. 2018 Sep 16;10(9):165-174
pubmed: 30283599
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):984-91
pubmed: 24913595
Obes Surg. 2017 Sep;27(9):2279-2289
pubmed: 28405878
Obes Surg. 2005 Oct;15(9):1304-8
pubmed: 16259892
Obes Surg. 2018 May;28(5):1188-1206
pubmed: 29600339
Obes Surg. 2018 Dec;28(12):3783-3794
pubmed: 30121858
Obes Surg. 2018 Nov;28(11):3586-3594
pubmed: 30047101
Obes Surg. 2019 Sep;29(9):3039-3046
pubmed: 31250385
J Minim Access Surg. 2019 Feb 18;:
pubmed: 30777997
Ann Surg. 2005 Jul;242(1):20-8
pubmed: 15973097

Auteurs

Maud Neuberg (M)

Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France. maud.neuberg@gmail.com.

Marie-Cécile Blanchet (MC)

Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France.

Benoit Gignoux (B)

Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France.

Vincent Frering (V)

Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH